Evidence map›Paper›PMID 36431841›Full record

ArticleMolecules (Basel, Switzerland)2022

Acute Toxicity and Anti-Inflammatory Activity of

Agerdânio Andrade de Souza, Brenda Lorena Sánchez Ortíz, Swanny Ferreira Borges, Andria Vanessa Pena Pinto, Ryan da Silva Ramos, Igor Colares Pena, Rosemary de Carvalho Rocha Koga, Carla Estefani Batista, Gisele Custódio de Souza, Adriana Maciel Ferreira and 2 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Larvicidal Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Toxicity and Anti-inflammatory Effects ofAnti-inflammatory & anti-allergy agents in medicinal chemistry · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Agerdânio Andrade de SouzaPost-Graduate Program in Pharmaceutical Innovation, Pharmacy Course, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, Macapá CEP 68903-419, Amapá, Brazil.
Brenda Lorena Sánchez OrtízResearch Laboratory of Drugs, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, km 02, Macapá CEP 68903-419, Amapá, Brazil.
Swanny Ferreira BorgesPost-Graduate Program in Pharmaceutical Innovation, Pharmacy Course, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, Macapá CEP 68903-419, Amapá, Brazil.
Andria Vanessa Pena PintoResearch Laboratory of Drugs, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, km 02, Macapá CEP 68903-419, Amapá, Brazil.
Ryan da Silva RamosGraduate Program in Biotechnology and Biodiversity-Network BIONORTE, Federal University of Amapá, Macapá CEP 68903-419, Amapá, Brazil.
Igor Colares PenaLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá CEP 68902-280, Amapá, Brazil.
Rosemary de Carvalho Rocha KogaPost-Graduate Program in Pharmaceutical Innovation, Pharmacy Course, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, Macapá CEP 68903-419, Amapá, Brazil.ORCID 0000-0003-1790-3794
Carla Estefani BatistaSchool of Technology, University of the State of Amazonas-UEA, Manaus CEP 69050-020, Amazonas, Brazil.ORCID 0000-0002-4470-8727
Gisele Custódio de SouzaPost-Graduate Program in Pharmaceutical Innovation, Pharmacy Course, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, Macapá CEP 68903-419, Amapá, Brazil.
Adriana Maciel FerreiraPost-Graduate Program in Pharmaceutical Innovation, Pharmacy Course, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, Macapá CEP 68903-419, Amapá, Brazil.
Sergio Duvoisin JuniorSchool of Technology, University of the State of Amazonas-UEA, Manaus CEP 69050-020, Amazonas, Brazil.
José Carlos Tavares CarvalhoPost-Graduate Program in Pharmaceutical Innovation, Pharmacy Course, Department of Biological and Health Sciences, Federal University of Amapá, Rodovia Juscelino Kubitschek, Macapá CEP 68903-419, Amapá, Brazil.ORCID 0000-0003-3662-9794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The species Trattinnickia rhoifolia Willd, (T. rhoifolia), which belongs to the Burseraceae family, is widely used in ethnopharmacological cultural practices by traditional Amazonian people for anti-inflammatory purposes, sometimes as their only therapeutic resource. Although it is used in teas, infusions, macerations and in food, the species is still unexplored in regard to its pharmacophoric potential and chemical profile. Therefore, the aim of this study was to conduct a phytochemical characterization of the hydroethanolic extract of T. rhoifolia leaves (HELTr) and to evaluate the acute toxicity and anti-inflammatory activity of this species using zebrafish (Danio rerio). The extract was analyzed by gas chromatography−mass spectrometry (GC-MS). The evaluation of the acute toxicity of the HELTr in adult zebrafish was determined using the limit test (2000 mg/kg), with behavioral and histopathological evaluations, in addition to the analysis of the anti-inflammatory potential of HELTr in carrageenan-induced abdominal edema, followed by the use of the computational method of molecular docking. The phytochemical profile of the species is chemically diverse, suggesting the presence of the fatty acids, ester, alcohol and benzoic acid classes, including propanoic acid, ethyl ester and hexadecanoic acid. In the studies of zebrafish performed according to the index of histopathological changes (IHC), the HELTr did not demonstrate toxicity in the behavioral and histopathological assessments, since the vital organs remained unchanged. Carrageenan-induced abdominal edema was significantly reduced at all HELTr doses (100, 200 and 500 mg/kg) in relation to the negative control, dimethyl sulfoxide (DMSO), while the 200 mg/kg dose showed significant anti-inflammatory activity in relation to the positive control (indomethacin). With these activities being confirmed by molecular docking studies, they showed a good profile for the inhibition of the enzyme Cyclooxygenase-2 (COX-2), as the interactions established at the sites of the receptors used in the docking study were similar to the controls (RCX, IMN and CEL). Therefore, the HELTr has an acceptable degree of safety for acute toxicity, defined in the analysis of behavioral changes, mortality and histopathology, with a significant anti-inflammatory action in zebrafish at all doses, which demonstrates the high pharmacophoric potential of the species. These results may direct future applications and drug development but still require further elucidation.

Indexed as

BurseraceaeZebrafishAnimalsAnti-Inflammatory AgentsCarrageenanEdemaEstersMolecular Docking SimulationPhytochemicalsPlant ExtractsAnti-Inflammatory AgentsCarrageenanEstersPhytochemicalsPlant Extractsanti-inflammatoryethnomedicinemolecular dockingpreclinical trialsTrattinnickia

Identifiers

PMID36431841
PMCPMC9699319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.